- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Is Novo Nordisk Stock a Buy?
January 18, 2025
From Motley Fool
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
From Benzinga
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
January 17, 2025
From Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
January 17, 2025
From Motley Fool
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
January 17, 2025
From Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
January 16, 2025
Tickers
LLY
From Benzinga
From Benzinga
9 of the 10 Largest Companies in the World Are Making Big Moves Into AI. Here's Why Investors Should Pay Attention.
January 16, 2025
From Motley Fool
My 10 Top Stocks to Buy to Start the New Year Off Right
January 16, 2025
From Motley Fool
From Benzinga
Microsoft, Applied Digital, Rigetti Computing, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 14, 2025
From Benzinga
Stocks Fail To Rise Despite Benign Producer Inflation, 30-Year Treasury Yields Hit 5%, Ely Lilly Tumbles: What's Driving Markets Tuesday?
January 14, 2025
From Benzinga
From Motley Fool
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks
January 14, 2025
From Benzinga
From Motley Fool
Eli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer Program For $2.5 Billion
January 13, 2025
From Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
January 09, 2025
From Benzinga
Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment
January 09, 2025
From Benzinga
3 Stocks to Buy for 2025 That Are Practically Money Machines
January 09, 2025
From Motley Fool
Best Healthcare Stock to Buy: Eli Lilly vs. Novo Nordisk
January 08, 2025
From Motley Fool
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
January 08, 2025
From Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
January 07, 2025
Tickers
LLY
From Benzinga
Investors Look Back at 2024
January 06, 2025
From Motley Fool
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
From Benzinga
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
January 06, 2025
From Benzinga
Prediction: These 3 Healthcare Stocks Will Soar in 2025
January 04, 2025
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.